Oroxin A, a flavonoid derivative isolated from Scutellaria baicalensis Georgi., exerts its anticancer effects on CRC by mediating aerobic glycolysis in a p53-dependent manner both in vivo and in vitro. The gene discussed is TP53; the disease is colorectal carcinoma.